在继续或切换到基于多拉维林的治疗方案后,与体重变化相关的因素
Chloe Orkin1, John R Koethe2, Princy N Kumar3
1SHARE Collaborative, Blizard Institute, Queen Mary University of London, London, UK.
Open forum infectious diseases
|November 24, 2025
概括
切换到多拉维林治疗艾滋病毒-1治疗方案通常是体重中和的. 然而,体重变化因患者人口统计和先前的抗逆转录病毒治疗方案而异.
科学领域:
- 传染性疾病 传染性疾病
- 病毒学 病毒学
- 临床药理学 临床药理学
背景情况:
- 对成年HIV-1感染者接受多拉维林抗逆转录病毒治疗的体重变化因子进行了检查.
- 第三阶段研究 (前进驱动,前进驱动,转换驱动) 评估了多拉维林的延续或切换.
研究的目的:
- 分析转换或继续多拉维林疗法后与体重变化 (减肥,稳定,增加) 相关的因素.
- 了解人口统计和先前的抗逆转录病毒治疗对体重变化的影响.
主要方法:
- 随机对照试验涉及多拉维林,达鲁纳维尔/里托纳维尔,埃法维伦兹和核酸逆转录酶抑制剂 (NRTIs).
- 一般化后勤模型分析了重量变化类别 (损失≥5%,稳定<5%,增益≥5%).
- 在96周的时间内,评估了持续治疗与转换为多拉维林的情况.
主要成果:
- 大多数 (74%) 接受多拉维林治疗的参与者也接受了特诺福维尔二氧化烟酸 (TDF) 治疗,体重保持稳定 (57%).
- 与黑人参与者相比,非黑人参与者更常见的体重减轻或稳定体重.
- 从抑制体重的非核糖逆转录酶抑制剂 (NNRTIs) 转换与体重增加有关.
结论:
- 切换到多拉维林的总体体重是中性的,但个体结果取决于人口统计和先前的治疗方案.
- 需要对代表性不足的人群进行进一步的研究,以充分解释观察到的体重变化模式.
相关概念视频
Therapeutic Drug Monitoring: Affecting Factors
183
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
183
Drug Dosing: Obese Patients
204
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
204
Drug Dosage Regimen: Overview
4.3K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
4.3K
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
797
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
797
Factors Affecting Drug Response: Overview
2.8K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.8K
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
224
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
224


